Comparing the current results to its competitors, Si Bone Inc reported Revenue increase in the 2 quarter 2026 by 17.16 % year on year. The sales growth was above Si Bone Inc 's competitors' average revenue growth of 8.04 %, achieved in the same quarter.
Si Bone Inc 's Comment on Competition and Industry Peers
The company operates in a competitive environment with primary competitors including Alphatec Holding Inc., Aurora Spine Corporation, Globus Medical, Inc., Medtronic plc., and Tenon Medical, Inc. Some of these competitors are large, publicly traded firms offering a broad range of spine and orthopedic surgery products, which allows them to bundle products and secure contracts with large hospital groups. These companies also benefit from integrated surgical navigation and robotics platforms, creating ecosystems around their implant systems that present market entry challenges. The 510(k) regulatory pathway and available predicate devices for sacroiliac fusion provide opportunities within this competitive landscape.
Overall company sales advanced by 17.16 % Si Bone Inc outperformed its competitors in this segment and improved market share, to approx. 0.12 %. << More on SIBN Market Share.
*Market share is calculated based on total revenue.
Apyx Medical Corporation follows a business model that centers around the development, manufacturing, and marketing of medical devices used in the field of aesthetics and surgical markets. The company focuses on creating innovative products that improve patient outcomes and enhance the effectiveness of surgical procedures. Apyx Medical Corporation sells its devices primarily through a direct sales force in the United States, while utilizing a combination of direct sales representatives and distributors in international markets.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Medinotec Inc is a medical technology company that operates on a business model focused on developing and providing innovative healthcare solutions, such as medical devices and software, to improve patient care and outcomes. Their products and services cater to healthcare professionals and institutions, offering advanced technology solutions in the medical field.
Orthopediatrics Corp is a medical device company specializing in orthopedic implants and instruments for children with orthopedic conditions. Their business model revolves around designing, manufacturing, and distributing innovative pediatric orthopedic products to healthcare providers worldwide. By focusing solely on pediatric patients, they aim to address the unique needs and challenges in this niche market, providing quality solutions for improved pediatric orthopedic care.
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
Sources:
Si bone inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Si bone inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
